Peter D. Kwong

National Institutes of Health — United States

Immunology and Microbiology · Life Sciences

122h-index67.7kcitations724works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(394), Monoclonal and Polyclonal Antibodies Research(267), HIV/AIDS drug development and treatment(138), Immune Cell Function and Interaction(136), SARS-CoV-2 and COVID-19 Research(104)

Publications722 total

Demonstration of <i>in vivo</i> efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodies
Journal of Virology·2025· 1 citedOpen Access
Novel Lineages of SARS-CoV-2 Receptor Binding Domain Monoclonal Antibodies Demonstrate Broad and Potent Neutralization Across SARS-CoV-2 and Other Sarbecoviruses 9206
The Journal of Immunology·2025Open Access
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B
Nature Microbiology·2025· 6 citedOpen Access
No evidence of direct activation of human neutrophil responses by multivalent prefusion trimeric SARS-CoV-2 Spike protein ex vivo
PLoS ONE·2025Open Access
Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization Breadth
Vaccines·2025Open Access
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus Macaques
2025Open Access
Anti-Malaria Antibody Engineering Broadens Recognition Motifs and Reveals New Homotypic Interactions that Enhance Protective Breadth
2025Open Access
Yeast Display Reveals Plentiful Mutations that Improve Fusion-Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1-Neutralization Breadth
Preprints.org·2025Open Access
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21
2025Open Access
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins
Science Translational Medicine·2025· 1 citedOpen Access
Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile
Antimicrobial Agents and Chemotherapy·2025Open Access
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody
Structure·2025Open Access
Improved targeting and elicitation of VRC01-class precursors by an optimized glycan-masking mutant of OD-GT8
2025Open Access
Systemic and Mucosal Humoral Immune Responses to Lumazine Synthase 60-mer Nanoparticle SARS-CoV-2 Vaccines
Vaccines·2025· 1 citedOpen Access
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies
The Journal of Experimental Medicine·2025· 5 citedOpen Access
In silico improvement of affinity for highly protective anti-malarial antibodies
iScience·2025· 3 citedOpen Access
Structural insights from vaccine candidates for EV-D68
Communications Biology·2025· 1 citedOpen Access
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques
Cell Reports·2025· 1 citedOpen Access
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults
The Lancet HIV·2025· 4 cited
Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening
Nature Communications·2025· 5 citedOpen Access
page 1 of 37Next →

Frequent Co-authors

John R. Mascola(23), Tongqing Zhou(21), Richard T. Wyatt(16), Ivelin S. Georgiev(15), Baoshan Zhang(15), Joseph Sodroski(14), Yongping Yang(14), Lawrence Shapiro(13), Gary J. Nabel(11), Dennis R. Burton(11), Marie Pancera(11), Mark K. Louder(10), Mark Connors(10), Barton F. Haynes(10), Sijy O’Dell(9), Jason Gorman(9), Michael Joyce(9), Aliaksandr Druz(9), Nicole A. Doria‐Rose(8), Barney S. Graham(8)